Rainbow Childrens Medicare Limited
All news and filings related to Rainbow Childrens Medicare Limited.
View all news & filings- Medium impact
Rainbow Children's Medicare Rating Reaffirmed at [ICRA] AA(Stable) by ICRA
ICRA Limited has reaffirmed Rainbow Children's Medicare Limited's credit rating to [ICRA] AA with a Stable outlook. This rating is a reaffirmation of the previously assigned rating and applies to the company's Issuer Rating. The rating is subject to ongoing surveillance and potential review.
Read the summary - Low impact
Rainbow Childrens Medicare Limited Closes Trading Window from Oct 1, 2026 for Q2 FY27 Results
Rainbow Children’s Medicare Limited will close its trading window from October 1, 2026. The window will reopen 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.
Read the summary - Medium impact
Rainbow Medicare Appoints Sudarshan Patodia as Group CFO
Rainbow Children's Medicare Limited appointed Mr. Sudarshan Patodia as Group Chief Financial Officer, effective September 23, 2026. Mr. Patodia brings nearly two decades of finance experience across healthcare and other sectors. The board also approved amendments to the company's materiality policy.
Read the summary - Low impact
Rainbow Children's Medicare Grants 55,690 Stock Options Under ESOP 2025
Rainbow Children's Medicare granted 55,690 stock options under ESOP 2025 on Sep 23, 2026. Options are exercisable at a discount to market price. 5387 options vested and 1922 exercised, realizing ₹23.95 lakh.
Read the summary - Low impact
Rainbow Children's Medicare Appoints Key Personnel for Disclosure Authority
Rainbow Children's Medicare Limited has designated key managerial personnel authorized to determine materiality and make disclosures to stock exchanges as per SEBI regulations. The authorized individuals include the Chairman & MD, CEO, CFO, and Company Secretary.
Read the summary - Medium impact
Rainbow Medicare Appoints Mr. Sudarshan Patodia as CFO, Approves Policy Amendments
Rainbow Children’s Medicare Limited appointed Mr. Sudarshan Patodia as CFO and Group CFO, effective September 23, 2026. Mr. Patodia is a Chartered Accountant with extensive experience in finance. The Board also approved amendments to the Policy on Determination of Materiality of Events / Information.
Read the summary - Medium impact
Rainbow Children's Medicare Commences Operations of New 50-Bed Hospital in Guntur
Rainbow Children’s Medicare Limited has commenced operations of its 50-bed women’s and children’s hospital in Guntur, Andhra Pradesh. This expansion was previously disclosed on July 29, 2026.
Read the summary - Low impact
Rainbow Children's Medicare to Participate in Multiple Investor Meetings in September 2026
Rainbow Children’s Medicare Limited will attend in-person investor meetings in September 2026. These include the Kotak Healthcare Forum on September 18, the Anand Rathi G-200 Summit on September 21, and the J.P. Morgan Flagship India Conference on September 22, all in Mumbai.
Read the summary - Low impact
Rainbow Children's Medicare: Chief Strategy Officer Srinath Metla Resigns
Mr. Srinath Metla, Chief Strategy and Growth Officer at Rainbow Children’s Medicare, has resigned due to personal reasons. His last day will be September 5, 2026. The company has accepted his resignation and thanked him for his contributions.
Read the summary - Medium impact
Rainbow Children's Medicare: CFO Vikas Maheshwari Resigns Effective Aug 31
Rainbow Children's Medicare Limited accepted the resignation of CFO and KMP, Mr. Vikas Maheshwari, effective August 31, 2026, due to personal reasons. The company is in the process of identifying a new candidate for the CFO position.
Read the summary - Medium impact
Rainbow Children's Medicare Completes 64% Acquisition in Super Prime Medical Care LLP
Rainbow Children's Medicare Limited has completed the acquisition of a 64% partnership interest in Super Prime Medical Care LLP. This follows an agreement signed on July 29, 2026. The transaction was finalized on August 14, 2026.
Read the summary - High impact
Rainbow Children's Medicare Q1 FY27 Earnings Call Transcript Released
Rainbow Children's Medicare released its Q1 FY27 earnings call transcript. Revenue grew 33% YoY to ₹470 crores, and EBITDA rose 30% YoY to ₹134.6 crores. The company plans to add 2,500 beds in 5 years with ₹2,200 crores capex. New hospitals are planned in Mumbai, Nellore, Guntur, Indore, Coimbatore, and Gurgaon. Revenue is projected to cross ₹2,000 crores this fiscal year.
Read the summary - Low impact
Rainbow Children's Medicare Q1 FY27 Earnings Call Audio Recording Available
Rainbow Children's Medicare has released the audio recording of its Q1 FY27 earnings conference call, held on July 31, 2026. The call discussed the financial and operational performance for the quarter ended June 30, 2026. The recording is available on the company's website.
Read the summary - Low impact
Rainbow Children's Medicare Ltd. Q1 FY27 Results Announced July 30, 2026
Rainbow Children's Medicare Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved by the Board on July 30, 2026, and published on July 31, 2026.
Read the summary - High impact
Rainbow Children's Medicare Q1 FY27 Revenue Surges 33% YoY to ₹470 Crore; Expands to Mumbai
Rainbow Children's Medicare reported Q1 FY27 revenue of ₹470 crore, up 33% YoY. EBITDA stood at ₹134.6 crore with a 28.6% margin. The company is expanding to Mumbai with a 100-bed hospital and acquiring hospitals in Nellore and Guntur, Andhra Pradesh.
Read the summary - Low impact
Rainbow Children's Medicare Q1 FY27 Earnings Presentation Shared
Rainbow Children's Medicare Limited released its unaudited financial results for Q1 FY27 ended June 30, 2026. The company has shared its earnings presentation with analysts and investors, detailing both standalone and consolidated financial performance for the quarter.
Read the summary - High impact
Rainbow Children's Medicare Releases Q1 FY27 Earnings Presentation
Rainbow Children's Medicare released its Q1 FY27 earnings presentation. Revenue from operations increased 33% YoY to ₹4,699.9 million. EBITDA grew 33% to ₹1,082.2 million, and profit rose 16% to ₹625.4 million. The company plans to add 630 beds by FY29, with key acquisitions integrated into its expansion strategy.
Read the summary - Low impact
Rainbow Medicare Grants 2,570 Stock Options Under ESOP 2025
Rainbow Children's Medicare Limited granted 2,570 stock options under ESOP 2025 to Anshuman Jaiswal on July 30, 2026. Options are exercisable at a discount up to 20% of the previous day's closing price. A separate 5,387 options vested on July 26, 2025.
Read the summary - Medium impact
Rainbow Children's Medicare Appoints Anshuman Jaiswal as Chief Legal Officer
Rainbow Children's Medicare Limited appointed Anshuman Jaiswal as Chief Legal Officer and Senior Management Personnel. The company also announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board meeting was held on July 30, 2026.
Read the summary - High impact
Rainbow Children's Medicare Declares Q1 FY27 Results; Appoints Anshuman Jaiswal as Chief Legal Officer
Rainbow Children's Medicare reported Q1 FY27 results with consolidated revenue at ₹469.99 crore and PAT at ₹625.40 crore. Mr. Anshuman Jaiswal was appointed Chief Legal Officer. The company is also set to acquire a hospital in Nellore for ₹19.8 crore, with completion expected in Q2 FY27.
Read the summary - Medium impact
Rainbow Children's Medicare Q1 FY27 Results: Profit Declines Amidst Strategic Acquisitions
Rainbow Children's Medicare reported Q1 FY27 results with standalone profit after tax at ₹527.06 million and consolidated at ₹625.40 million. Mr. Anshuman Jaiswal was appointed Chief Legal Officer. The company is acquiring a 64% stake in Super Prime Medical Care LLP for ₹198 million and developing a new hospital in Mumbai, both expected to complete by Q2 FY27.
Read the summary - Medium impact
Rainbow Children's Medicare to add 50 beds at Guntur hospital with ₹15 Crore investment
Rainbow Children's Medicare is adding 50 beds with a new women's and children's hospital in Guntur, Andhra Pradesh. The expansion requires an investment of approximately ₹15 Crore, funded by internal accruals. The new facility is expected to be commissioned by September 2026.
Read the summary - Medium impact
Rainbow Medicare to Acquire 64% Stake in Super Prime Medical Care for ₹19.84 Cr
Rainbow Children's Medicare Limited will acquire a 64% stake in Super Prime Medical Care LLP for ₹19.84 Cr, making it a subsidiary. The deal, expected by August 31, 2026, aims to add 70 beds in Nellore, Andhra Pradesh, enhancing the company's regional presence and hub-and-spoke model. The investment will be funded by internal accruals.
Read the summary - Medium impact
Rainbow Medicare to Acquire 64% Stake in Super Prime Medical Care for ₹19.84 Cr
Rainbow Children's Medicare is acquiring a 64% stake in Super Prime Medical Care LLP for ₹19.84 Cr. The LLP operates a 70-bed hospital in Nellore, Andhra Pradesh. The acquisition is expected to be completed by August 31, 2026, and will make the LLP a subsidiary. The company plans to add 30 beds to the hospital.
Read the summary - Medium impact
Rainbow Children's Medicare to Invest ₹90 Crore for New Hospital in Malad, Mumbai
Rainbow Children's Medicare will invest ₹90 Crore for a new 100-bed hospital in Malad, Mumbai, via its subsidiary RWCHPL. Fountainhead TCHM Healthcare LLP will acquire a 24% stake in RWCHPL. The project is expected by Q1 FY28, financed by internal accruals.
Read the summary - Medium impact
Rainbow Medicare to Add 100 Beds Hospital in Malad, Mumbai for ₹90 Crore
Rainbow Children's Medicare will develop a new 100-bed hospital in Malad, Mumbai, with an estimated project cost of ₹90 Crore. Fountainhead TCHM Healthcare LLP will acquire a 24% stake in the subsidiary undertaking the project. The hospital is expected to be commissioned by Q1 FY28.
Read the summary - High impact
Rainbow Children's Medicare to invest ₹90 Cr for new hospital, inducts Fountainhead LLP with 24% stake
Rainbow Children's Medicare will invest approximately ₹90 Crore to develop a new 100-bed children's and women's hospital in Malad, Mumbai. Its subsidiary, RWCHPL, will induct Fountainhead TCHM Healthcare LLP, which will acquire a 24% stake. The project is expected to be commissioned by Q1 FY28, financed through internal accruals.
Read the summary - Low impact
Rainbow Children's Medicare Limited Holds 28th AGM on July 29, 2026
Rainbow Children's Medicare Limited held its 28th AGM on July 29, 2026. The company declared a dividend of ₹3.5 per equity share for FY26. Key management and directors were present. E-voting results will be announced by July 31, 2026.
Read the summary - Low impact
Rainbow Children's Medicare to Host Q1FY27 Earnings Conference Call on July 31, 2026
Rainbow Children's Medicare Limited will host an Earnings Conference Call on July 31, 2026, at 10:00 AM IST to discuss Q1FY27 financial results. Key management personnel will participate. The call aims to cover the company's financial and operating performance for the quarter ended June 30, 2026.
Read the summary - Low impact
Rainbow Children's Medicare receives 'Strong' ESG rating of 61 from CRISIL ESG
Rainbow Children’s Medicare Limited received an ESG rating of 61 and a Core ESG rating of 73 from CRISIL ESG for FY 2025-26. The ESG rating improved from "Adequate" to "Strong". CRISIL ESG prepared the report independently.
Read the summary - Low impact
Rainbow Children's Medicare: AGM on July 29, FY26 Annual Report Dispatched
Rainbow Children's Medicare will hold its 28th AGM on July 29, 2026. The FY26 Annual Report has been dispatched. A final dividend of ₹3.50 per share is recommended, payable to shareholders on record by July 21, 2026. E-voting is open from July 25 to July 28, 2026.
Read the summary - Low impact
Rainbow Childrens Medicare Disseminates Integrated Annual Report for FY25-26
Rainbow Children’s Medicare Limited has disseminated its Integrated Annual Report for FY25-26. The report is available via a web link and QR code for shareholders whose email addresses are not registered. This follows SEBI Listing Regulations for disclosure.
Read the summary - Low impact
Rainbow Childrens Medicare Files BRSR Report for FY26
Rainbow Children’s Medicare Limited has filed its Business Responsibility and Sustainability (BRSR) Report for FY 2025-26. The report covers consolidated operations, with 100% of business in medical services across 23 hospitals and 5 clinics. The company employed 6,397 individuals as of FY26. It details sustainability initiatives, risk management, and employee well-being programs.
Read the summary - Low impact
Rainbow Children's Medicare to hold 28th AGM on July 29, 2026
Rainbow Children’s Medicare Limited will hold its 28th Annual General Meeting (AGM) on July 29, 2026. The company has also submitted its Integrated Annual Report for FY 2026, containing the AGM notice, which is available on its website.
Read the summary - Low impact
Rainbow Children's Medicare Announces 28th AGM on July 29, 2026, Via VC/OAVM
Rainbow Children's Medicare will hold its 28th AGM on July 29, 2026, via VC/OAVM. The board recommended a final dividend of ₹3.5 per equity share for FY26, with a record date of July 21, 2026. The AGM notice and annual report will be sent electronically.
Read the summary - High impact
Rainbow Children's Medicare Q4 FY26 Earnings Call Transcript Released
Rainbow Children's Medicare released its Q4 & FY26 earnings call transcript. FY26 saw record capacity addition of 500 beds and 20% YoY revenue growth. Q4 FY26 revenue grew 24% to ₹459.9 crore, with PAT up 38% to ₹78.2 crore. FY26 revenue was ₹1,703 crore. The company has a strong liquidity of ₹594 crore and no debt, funding expansion through internal accruals.
Read the summary - Low impact
Rainbow Childrens Medicare: Audio Recording of Q4 & FY26 Earnings Call Available
Rainbow Children's Medicare has released the audio recording of its Q4 & FY26 earnings conference call held on May 25, 2026. The call discussed financial and operational performance for the year ended March 31, 2026. The recording is available on the company's website.
Read the summary - Medium impact
Rainbow Childrens Medicare Limited Publishes Q4 FY26 Financial Results
Rainbow Children's Medicare Limited reported Q4 FY26 results on May 23, 2026. Total income from operations for the quarter was ₹3,550.53 lakh, with a net profit after tax of ₹1,171.09 lakh. For the full year, total income was ₹10,670.65 lakh and net profit after tax was ₹2,386.34 lakh. EPS for the year was ₹2.58.
Read the summary - High impact
Rainbow Children's Medicare Approves FY26 Results, Re-appoints Key Directors, Declares Dividend
Rainbow Children's Medicare approved FY26 audited results and recommended a final dividend of ₹3.5 per share. The 28th AGM is on July 29, 2026, with July 21, 2026, as the record date. Dr. Ramesh Kancharla and Dr. Dinesh Kumar Chirla were re-appointed as CMD and Whole-Time Director, respectively, for five years from August 11, 2026. Independent Directors Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati were also re-appointed.
Read the summary - Medium impact
Rainbow Children's Medicare Approves FY26 Results, Reappoints Key Directors, Declares Dividend
Rainbow Children's Medicare approved FY26 financial results and recommended a final dividend of ₹3.5 per share. The 28th AGM will be on July 29, 2026. Key directors Dr. Ramesh Kancharla, Dr. Dinesh Kumar Chirla, Mr. Santanu Mukherjee, and Ms. Sundari R. Pisupati were re-appointed.
Read the summary - Medium impact
Rainbow Children's Medicare Approves Q4FY26 Results, Reappoints Key Directors, Declares Dividend
Rainbow Children's Medicare approved Q4FY26 results. Recommended a final dividend of ₹3.5 per share. The 28th AGM is on July 29, 2026. Dr. Ramesh Kancharla and Dr. Dinesh Kumar Chirla reappointed as CMD and Whole Time Director respectively for 5 years. Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati reappointed as Independent Directors.
Read the summary - Medium impact
Rainbow Children's Medicare Approves FY26 Audited Results, Reappoints Key Directors, Declares Dividend
Rainbow Children's Medicare approved FY26 audited results and recommended a final dividend of ₹3.5 per share. The 28th AGM is on July 29, 2026, with July 21, 2026, as the record date. Key appointments include Dr. Ramesh Kancharla as CMD and Dr. Dinesh Kumar Chirla as Whole Time Director for five-year terms.
Read the summary - Medium impact
Rainbow Children's Medicare Approves FY26 Results, Reappoints Key Directors, Declares Dividend
Rainbow Children's Medicare approved FY26 results and recommended a final dividend of ₹3.5 per share. The 28th AGM is on July 29, 2026, with July 21, 2026, as the record date. Key directors Dr. Ramesh Kancharla, Dr. Dinesh Kumar Chirla, Mr. Santanu Mukherjee, and Ms. Sundari R. Pisupati were re-appointed for five-year terms.
Read the summary - Low impact
Rainbow Medicare Grants 2.67 Lakh Stock Options Under ESOP 2025
Rainbow Children's Medicare Limited granted 2,67,550 stock options under its ESOP Scheme 2025 on May 23, 2026. The exercise price is at a discount of up to 20% of the closing price on May 22, 2026. Vesting occurs between 1-10 years, and options are exercisable within 2 years post-vesting.
Read the summary - High impact
Rainbow Children's Medicare Presents Q4 FY26 Audited Financial Results and Investor Presentation
Rainbow Children’s Medicare reported Q4 FY26 audited financial results. Revenue increased by 24% YoY to ₹4,599 million, EBITDA by 26% YoY to ₹1,447 million, and PAT by 38% YoY to ₹782 million. For FY26, revenue was ₹17,031 million (up 12% YoY), EBITDA ₹5,442 million (up 11% YoY), and PAT ₹2,815 million (up 15% YoY). The company also announced the commencement of new facilities in Bengaluru.
Read the summary - High impact
Rainbow Children's Medicare Q4 FY26 Revenue Up 24.3% to ₹4,599 Crore, PAT Rises 38.3%
Rainbow Children’s Medicare reported Q4 FY26 revenue of ₹4,599 million, up 24.3% YoY. PAT grew 38.3% to ₹782 million. FY26 revenue increased 12.4% to ₹17,031 million, with PAT up 15.3% to ₹2,815 million. The company recommended a final dividend of 35% and is shifting focus to execution and operational optimization.
Read the summary - Medium impact
Rainbow Children's Medicare Board Approves FY26 Results, Recommends Dividend, Reappoints Directors
Rainbow Children's Medicare's Board approved FY26 audited results and recommended a final dividend of ₹3.50 per share. The 28th AGM is set for July 29, 2026, with July 21, 2026, as the record date. Key management including Dr. Ramesh Kancharla and Dr. Dinesh Kumar Chirla were re-appointed for five-year terms.
Read the summary - Medium impact
Rainbow Children's Medicare Board Approves Final Dividend of ₹3.5/Share, Reappoints CMD
Rainbow Children's Medicare Board approved audited financial results for FY26. A final dividend of ₹3.5 per share was recommended, subject to shareholder approval at the AGM on July 29, 2026. Record date set for July 21, 2026. Dr. Ramesh Kancharla re-appointed CMD for five years.
Read the summary - Medium impact
Rainbow Children's Medicare Approves FY26 Audited Results, Recommends ₹3.5 Dividend, Sets AGM Date
Rainbow Children's Medicare approved audited FY26 results and recommended a final dividend of ₹3.5 per share. The 28th AGM is set for July 29, 2026, with July 21, 2026, as the record date. Key management re-appointments include Dr. Ramesh Kancharla (CMD) and Dr. Dinesh Kumar Chirla (Whole Time Director) for five-year terms.
Read the summary - Low impact
Rainbow Children's Medicare to Host Earnings Conference Call on May 25, 2026
Rainbow Children’s Medicare Limited will host an Earnings Conference Call on May 25, 2026, at 10:00 AM IST. The call will discuss financial and operating performance for Q4 and FY2025-26. Key management personnel will participate in the discussion.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio